Multiple Ascending Dose (MDX1105-01)

NCT00729664 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
281
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb